On 22.03.2023, the networking meeting of the BMBF funding measures “Gründungen: Innovative Start-ups for Human-Technology Interaction” (START MTI) and “START-interactive: Interactive Technologies for Health and Quality of Life” (START-i) took place. With START, the BMBF
At the 3rd trilateral Japanese-French-German Symposium on Artificial Intelligence (AI) in Tokyo, experts from academia, industry, and policy-making gathered to discuss measures for tackling planetary challenges and realizing a sustainable society. Dr. Simon Stock from
From 07/05 – 07/07/2022, Markus Schinle from Metis Neurotec explored the LifeScience, MedTech and AI market in Switzerland. The trip to the two top Swiss Life Science/ MedTech locations Basel and Zurich offered the perfect
We were interviewed by the KIT magazine “NEULAND” about our startup Metis Neurotec. In the magazine you can now read what makes our startup so special and which approaches we envision in our treatment concept
Worldwide, only 20-50% of all dementia cases are detected. Yet almost 90% of all physicians and patients surveyed call for early diagnosis in order to be able to respond to associated changes in care and
Markus Schinle Markus Schinle has an excellent academic record. His studies focused on the development of information systems, technology management and entrepreneurship and led to a M. Sc. degree in Information Engineering and Management at
Simon Stock Simon Stock is doing his PhD at KIT-ITIV under supervision of Prof. Stork in the field of AI-supported medical technology using brain-computer interfaces. He started a research collaboration with the Massachusetts Institute of
Marius Gerdes Marius Gerdes most recently completed his M. Sc. in Mechanical Engineering at the KIT Karlsruhe Institute of Technology. He gained experience abroad early on through a nine-year stay in Norway. He decided to
METIS Neurotec
Together against neurological diseases.
METIS was called into existence by funding from the Helmholtz Association in 2021.
Located in Karlsruhe, Germany, METIS aims to transfer deep tech to the field of dementia treatment and digital healthcare.